Phase IB Study of Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2018
At a glance
- Drugs Aravive S6 (Primary) ; Carboplatin; Paclitaxel
- Indications Adenocarcinoma; Carcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 21 Nov 2018 Planned End Date changed from 3 Dec 2025 to 3 Mar 2026.
- 21 Nov 2018 Planned primary completion date changed from 3 Dec 2020 to 3 Mar 2021.
- 21 Nov 2018 Planned initiation date changed from 31 Oct 2018 to 31 Jan 2019.